So NWBO SEC reported information, Dr. Liau's journal publication, NWBO press releases, FDA Guidance documents are B.S.?
Optune was approved for GBM, not mutations, etc. As DCVax-L has not been approved, doesn't seem to have any commercial organization, not going to be a SoC.
We'll see how this plays out but treatments don't become SoC without significant commercial support. NWBO has none.
Market Data 
Markets 
AI
